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Abstract 
This dissertation describes quantitative dynamic contrast enhanced magnetic 
resonance imaging (DCE-MRI), which is a powerful tool in diagnostics, mainly 
in oncology. After a time series of T1-weighted images recording contrast-agent 
distribution in the body has been acquired, data processing phase follows. It is 
presented step by step in this dissertation. the theoretical background in 
physiological and MRI-acquisition modeling is described together with 
the estimation process leading to parametric maps describing perfusion and 
microcirculation properties of the investigated tissue on a voxel-by-voxel basis. 
the dissertation is divided into this theoretical analysis and a set of publications 
representing particular contributions of the author to DCE-MRI. 
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Abstrakt 
Tato dizertační práce představuje metodu zobrazování perfúze magnetickou 
rezonancí, jež je výkonným nástrojem v diagnostice, především v onkologii. Po 
ukončení sběru časové sekvence T1-váhovaných obrazů zaznamenávajících 
distribuci kontrastní látky v těle začíná fáze zpracování dat, která je předmětem 
této dizertace. Je zde představen teoretický základ fyziologických modelů 
a modelů akvizice pomocí magnetické rezonance a celý řetězec potřebný k 
vytvoření obrazů odhadu parametrů perfúze a mikrocirkulace v tkáni. Tato 
dizertační práce je souborem uveřejněných prací autora přispívajícím k rozvoji 
metodologie perfúzního zobrazování a zmíněného potřebného teoretického 
rozboru. 
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1  INTRODUCTION 
1.1 QUANTITATIVE DYNAMIC CONTRAST ENHANCED MAGNETIC 
RESONANCE IMAGING 
 The quantitative dynamic contrast enhanced magnetic resonance imaging 
(DCE-MRI) is the topic of this thesis. DCE-MRI is a methodology, which consists 
of a series of estimation processes from the acquisition of the dynamic series of MRI 
images with contrast agent application to the formulation of parametric maps 
describing physiological properties of the tissue of interest. the physiological 
properties are parameters of a pharmacokinetic model. Based on the model used, it 
is possible to estimate plasma/blood flow, permeability of the capillary wall, 
volumes of plasma or extracellular extravascular spaces etc. These quantities, if 
estimated properly, are reproducible, allow inter- and intra-patient comparisons and 
describe undergoing physiological processes, which would allow us to make an 
inference about the state of the tissue, whether binary (physiological vs. 
pathological) or multary (diagnoses). 
 The standard DCE-MRI examination is done as follows. At the beginning, 
the subject (patient or animal) is placed into an MRI scanner and a scout images are 
acquired. After that a couple of native (pre-contrast) images is taken to allow further 
conversion of the data to the concentration of the contrast agent. Then the main 
acquisition starts to capture a sequence of T1-weighted images with the time 
resolution in the range of 1 to 30 or more seconds. During this acquisition, when 
a few baseline pre-contrast images have been acquired, a gadolinium-based contrast 
agent is injected into the subject's vein as a short bolus. After a few minutes, during 
which the contrast agent has been distributing throughout the body, DCE-MRI 
processing starts, since all the necessary data have been collected. This processing 
phase is the scope of this dissertation and is presented below. 
1.2 AIM OF THE DISSERTATION 
 The aim of this thesis was to contribute to a more widespread usage 
of the advanced processing methods in quantitative DCE-MRI including blind 
estimation of the arterial input function, the usage of complex pharmacokinetic 
models and precision description of the perfusion-parameter estimates. This can 
allow us to gain more information from the standard DCE-MRI acquisition. 
The specific aims were: 
1) To understand and remove convergence problems in nonlinear regression with 
adiabatic approximation of tissue homogeneity pharmacokinetic model (our 
reference [1] and Paper I) 
2) To analyze and describe the precision of the perfusion-parameter estimates 
and to transfer this precision to the derived perfusion parameters (Paper I). 
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3) To enable processing of datasets with missing or corrupted arterial input 
function (crucial component of the pharmacokinetic model) by using blind 
deconvolution algorithm to estimate it (Paper II) 
4) To contribute to application of these advanced processing methods in analysis 
of therapy response in oncology and validate these methods on relevant in-
vivo data (Paper III) 
2  MODELING 
2.1 PHARMACOKINETIC MODEL 
 Any perfused part of the body can be in 
general described by a tissue unit given in Figure 
2.1, where      is the molar concentration of an 
indicator (contrast agent) inside the modeled tissue 
(e.g. in mol/ml or M) and    
            
       are 
fluxes (in mol/min/ml) into and out of the system, respectively. If it is assumed that 
the system is completely described by the tissue unit and that no indicator can 
disappear nor be created inside the unit, such a system can be described by 
the general principle of conservation of indicator mass [2]: 
     
  
     
      
 
   
      
       
 
   
 (2.1) 
For linear and stationary (time-invariant) systems, the concept of transfer 
functions can be used. I.e. any output can be described as a linear combination 
of inputs: 
    
           
      
 
   
           (2.2) 
where           is a transfer function or the probability distribution of transit times 
from the i-th input to the o-th output and  is the convolution operator defined as: 
                           
 
 
  (2.3) 
Because of the mass conservation principle or the fact that each             is 
a probability density function of transit times, the function             must fulfil 
the following: 1) the area is equal to 1; 2) all values are positive; 3) any          
    , the system is causal. 
     
   
   
 
   
   
 
    
   
 
    
   
 
Figure 2.1: General tissue unit with I 
inlets and O outlets 
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2.1.1 Impulse residue function 
 After the substitution of (2.2) into (2.1) and finding the solution of such 
differential equation by integration with initial condition          (see 
appendix in [3]), the concentration of the indicator in the tissue unit can be written 
as: 
                    
 
   
 
 
       
      
 
   
           
      
 
   
 (2.4) 
where       is an impulse residue function (or impulse response function). 
Transforming the properties of             from previous section,       is non-
negative, non-increasing function with           and              . 
the impulse residue function describes the probability that a particle, which has 
entered the tissue unit, is still inside the unit at time instant  . Equivalently, it is 
a response of the system to the Dirac impulse at the arterial input. the flux in linear 
and stationary systems can be understood as a function of concentration,      
      , where   is a rate constant also known as clearance (in ml/min/ml) and      
is indicator concentration at the given input of the tissue unit. If   describes 
the transport of the contrast agent by convection, it is the flow of the carrier fluid 
normalized to the volume of the unit tissue. With the assumption of only one arterial 
inlet, (2.4) can be converted to the well-established model: 
                              (2.5) 
where    is plasma flow (ml/min/ml) and        is the arterial input function 
(AIF), i.e. concentration of the contrast agent in the feeding artery. 
 The basic quantitative parameters which can be extracted from      or      
are plasma flow,   , mean transit time through the tissue unit,   (in min), and 
the fractional volume of the contrast-agent distribution space in the tissue unit,   
(ml/ml). Since          ,    is equal to: 
       .. (2.6) 
The mean transit time through the system is: 
         
 
 
 (2.7) 
and using the central volume theorem [2],      : 
                  
 
 
 
 
  (2.8) 
These physical quantities are usually connected with so called model-free analysis 
as no model is imposed to      or     . 
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 Another concept is called a model-based analysis 
[3] and assumes additional constraints on the possible 
form of     , which is equivalent to the assumptions 
about the inner architecture of the general tissue unit in 
Figure 2.1. These assumptions are a compromise between 
physiological realism of the model and model 
complexity. Assuming that the indicator enters 
the modeled tissue only through one inlet, exits only 
through one outlet and can freely diffuse from plasma 
space to extracellular extravascular space (EES) or vice 
versa through the capillary wall which is symmetrically permeable, such a model 
can be graphically represented as Figure 2.2. the concentration of the indicator inside 
the whole unit is a weighted sum of the concentrations in each region: 
                     (2.9) 
where       are (fractional) volumes of plasma and extravascular extracellular 
spaces (ml/ml), respectively and             are the corresponding indicator 
concentrations. 
Generalized kinetic model 
 One of the simplest models in tracer kinetic 
modeling is the so called generalized kinetic (GK) 
model [4] also known as the Tofts model [5] or 
the Kety model [6] according to the authors 
of the basic papers. the latter is one of the pioneering 
studies dating back to 1951. 
 The model is based on the assumption that 
the tissue is weakly vascularized (    ) thus 
the whole plasma space can be excluded from the model (see Figure 2.3 in comparison 
with Figure 2.2). However, not all indicator passes from plasma to the EES 
compartment (as it could be in the case of a standard one compartment model) but 
only a fraction   of it (unitless or %). After substitutions to equation (2.1) and using 
(2.9) with     , this model can be described by the standard ([4], [5], [7]) 
differential equation: 
     
  
                     (2.10) 
where            is the volume transfer constant and     is rate constant 
between plasma and EES defined as: 
    
      
  
  (2.11) 
Using Laplace transform to solve (2.10) gives: 
Figure 2.2: a non-specific tissue 
unit 
      
       
       
      
   
Figure 2.3: Generalized kinetic 
model 
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                   (2.12) 
Transforming this equation back to the time domain using inverse Laplace 
transform gives the known convolution formula (2.5) with the impulse residue 
function of the generalized kinetic model       : 
                                       (2.13) 
Extended generalized kinetic model 
 The extended generalized kinetic (EGK) model 
[4] also referred to as the extended Tofts model [3], [5], 
[7] is the most widespread model in DCE imaging. It is 
the GK model where the assumption about 
the negligible plasma space is not used. the plasma 
space is included in the model, but not as 
a compartment, rather the plasma concentration       
mimics the input concentration      , see Figure 2.4. 
 The derivation of the model is similar to the GK model except for 
the simplification (    ) of the equation (2.9). the differential equation has 
the same form as (2.10) and if it is solved together with (2.9) using 
the simplification            , it will lead to the following solution in the Laplace 
domain: 
         
      
     
                     (2.14) 
The transformation to the time domain is straightforward: 
              
                                  (2.15) 
but the interpretation of its impulse response         brings complications 
because of the Dirac impulse,     . 
Two compartment exchange model 
 The two compartment exchange model (2CXM) 
models both the plasma space and EES as compartments 
(Figure 2.5) thus it needs to be described by the system 
of two differential equations (2.16), (2.17). To find 
the concentration function of the whole tissue unit, it is 
necessary to substitute the solutions per each 
compartment into (2.9). 
  
      
  
                                 (2.16) 
  
      
  
                 (2.17) 
Using following substitutions for simplifications [2]: 
Figure 2.4: Extended 
generalized kinetic model 
      
      
      
       
  
   
Figure 2.5: Two compartment 
exchange model (2CXM) 
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       ,    
  
  
 and             (2.18) 
where         are mean transit times trough whole system, capillary plasma space 
and EES, respectively, the solution in the Laplace domain has the following form 
[2]: 
       
       
                
                       (2.19) 
The inverse Laplace transform gives the time-domain solution [2]: 
     
            
                  
     
     
       
          
                    
     
  
(2.20) 
The direct solution of the equations (2.16), (2.17) without the substitution can be 
found in [4]. 
Tissue homogeneity model 
 The tissue homogeneity (TH) model was 
developed in [8]. Its main limitation is that it has no 
closed-form time-domain solution thus its applications 
were for a long time limited only to few studies [9], 
[10]. This was until the publication of the paper 
of Garpebring et al. [11] which has shown that 
the Laplace domain solution is sufficient to describe 
the model in the Fourier domain, together with the use of the inverse fast Fourier 
transform (FFT - see section 3.5.1). the example shapes of the TH impulse response 
in the Fourier domain and in time domain using FFT are plotted in Figure 2.10. 
  
Figure 2.6: Typical shape of GK, EGK, 2CXM models in time (left) and Fourier amplitude (right) 
domains. the GK model coincides with the exponential part of the EGK model in time domain. 
Figure 2.7: Tissue homo-
geneity (TH) model  
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 The model is depicted in Figure 2.7 and its difference from the previous models 
lies in the modeling of the plasma space. the plasma space is no more understood as 
a well-mixed compartment but rather as a thin tube divided into infinitesimal 
subspaces which are not connected to its neighbors but are just constantly moving 
from the inlet to the outlet. the exchange of the indicator is allowed only between 
each subspace and the EES compartment. the physiological background behind is 
a blood flow through a thin capillary where red blood cells create "plugs" hence 
the name plug-flow for such plasma model. 
 The differential equations for the TH model are more complicated since 
the concentration         depends also on the spatial position   along the capillary 
and can be found in many papers [3], [7], [8], [10], [11], however the derivation 
of the solution in the Laplace domain can be found only in the original paper [8]. 
the revised result in [2] has the form: 
        
                      
          
                            
         
 
        
    
  
  
(2.21) 
Adiabatic approximation to the tissue homogeneity model 
 This model was developed in [12] and has 
quickly become popular for the estimation of plasma 
flow and capillary permeability [2], because unlike 
the TH model, it has a closed-form solution in 
the time domain. 
 As the name of the model indicates, this model 
is an approximation of the TH model using 
the adiabatic condition, i.e. the capillary-wall 
permeability is negligible in the arterial phase 
of the indicator distribution. This comes from 
the assumption that the indicator concentration changes in the EES are much slower 
in comparison with the plasma space changes. the adiabatic approximation to the TH 
model (ATH) is depicted in Figure 2.8. the exchange between the plasma and EES 
takes place only at the end of the capillary and the capillary itself represents only 
a delay unit. the derivation of the model can be found in the original paper [12]. 
the differential equations and the Laplace- (2.22) and time-domain solutions are 
based on (or can be found in) [2]. the Laplace-domain solution is 
          
        
 
 
    
     
   
  
  
  (2.22) 
However the authors of [2] omitted to analyze the existence of this functional 
form. It is evident that (2.22) is not defined for           and    . the former 
one is unimportant since all the parameters are real and positive but the latter one is 
      
      
      
   
        
Figure 2.8: Adiabatic approxi-
mation to the tissue homogeneity 
(ATH) model  
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crucial for the use with the inverse fast Fourier transform as proposed by [11] (see 
section 3.5.1). the definition of the ATH model for     can be found computing 
the limit: 
             
   
               (2.23) 
The same can be obtained intuitively since the zero (direct) component 
of a Laplace/Fourier-domain image is the area under the curve in the time domain, 
i.e. a sum of the plasma and EES volumes. the time-domain solution has the form: 
                               
 
   
  
 
                 
(2.24) 
where      is the Heaviside (unit step) function,       is the impulse response 
of the plasma space and       is the impulse response of the EES. 
Distributed parameter model 
 The original paper [13] describing the distributed 
parameter (DP) model was published in 1953, however 
its modern formulation in terms of impulse residue 
function for DCE-MRI studies starts with the paper 
[14]. 
 The plasma space is modeled as the plug-flow 
system as in the TH model but the indicator does not 
distribute from the capillary to the general EES 
compartment but to separate infinitesimal EES compartments, which are not 
interconnected to each other (see Figure 2.9). the consequence of it is that the indicator 
can only flow back to the position in the capillary, from where it has entered 
the EES. Hence the shortest path through the whole system, in comparison with 
the TH model, is through the capillary plasma space only.  
 The differential equation of the model can be found in [2], [4] but 
the derivation of the Laplace-domain solution needs to be found in [14]. After a few 
substitutions, it has the form [2]: 
         
   
   
       
     
 
  
(2.25) 
The function is not defined for     again so it is necessary to find the limit: 
            
   
                  (2.26) 
The expression           can be found using (2.18). the derivation 
of the time-domain solution can again be found in [14] (Equation (23a) and can be 
rewritten to [2]: 
                 
 
    
       
 
 
  
    
 
 
    
    
               (2.27) 
Figure 2.9: Distributed-
parameter (DP) model 
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where       is the first-order modified Bessel function of the first kind. As stated 
in [14], (2.27) needs numerical integration thus the author proposed a different 
description of        (see (23d) in [14]). However, since Garpebring et al. [11] has 
shown the use of Laplace domain solutions (section 3.5.1), the time-domain solution 
is not necessary. 
Distributed capillary/multiple pathway models 
 These models have been presented by Koh et al. [15], [16] and were revised 
by Schabel [17]. They represent a special group, where there is not only one tissue 
unit in a model, but there are multiple tissue subunits on different pathways 
of the vascular tree which are modeled using the ATH model (i.e. each tissue unit 
being characterized by a given capillary transit time) and all together represent 
the model of a tissue unit. the probability of the given pathway (tissue subunit) is 
represented by the probability distribution of the capillary transit time        , 
where   is a vector of parameters of the probability distribution. Incorporating this 
probability function into the standard theory of impulse residue function, Koh et al. 
[15] have introduced a formula for an impulse residue function of a distributed 
capillary model        as: 
                    
 
 
                 
 
 
 (2.28) 
where       is the EES impulse residue function of the tissue subunit used in 
each pathway (see the ATH model in 0). the last summand in (2.28) describes 
the impulse response of the EES and the rest describes the impulse response 
of the plasma space. the impulse residue function is then parameterized by 
the perfusion parameters of the ATH model plus additional parameters,  , 
  
Figure 2.10: Typical shape of TH, ATH, DP models in time (left) and Fourier amplitude (right) 
domains. the DP model almost coincides with the ATH model in time domain and all the models 
coincide in Fourier domain. 
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describing the probability distribution        . For example if         
      
    , i.e. the Gaussian distribution, it is one additional parameter  . 
 In the original paper [15], the distributed capillary adiabatic tissue 
homogeneity (DCATH) model was introduced. Three distribution functions have 
been investigated: normal distribution, truncated normal distribution and skewed 
normal distribution; together with the ATH model as an elementary unit. the middle 
one has been used in Paper I and Paper III because it has no step between 
the plasma and EES phases (see section 3.5.1). Since the normal distribution is 
disputable from the physiological point of view, Schabel [17] has developed so 
called gamma capillary transit time (GCTT) model. the only difference lies in 
the gamma distribution instead of the normal one. But the breakthrough lies in its 
ability to unify the GK, EGK, ATH and 2CXM models. Hence, depending on its 
parameters, the GCTT model can represent any of the above models. 
2.1.2 Arterial input function 
 It was shown in section 2.1.1 that the concentration of the indicator in a tissue 
can be described as convolution of the impulse residue function with an arterial 
input function (2.5), where the arterial input function (AIF) is the concentration 
of an indicator in a feeding artery of the investigated tissue. If the AIF has the form 
of a Dirac delta function, the concentration in the tissue is equal to the impulse 
residue function multiplied by   , i.e.     . 
 Unfortunately, this ideal case is unreachable in perfusion experiments thus 
the AIF needs to be estimated. One possible way is to use mathematical models, 
which allow mathematical description of the AIF shape. However, the parameters 
of the model need to be setup properly so that the model approximates the real AIF. 
Hence, it is necessary to estimate the AIF parameters by an experiment. 
  
Figure 2.11: Typical shape of DCATH and GCTT models in time (left) and Fourier amplitude (right) 
domains. Both models are rendered using FFT in Fourier domain. 
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Bi-exponential model 
 The bi-exponential model is well-known from the pharmacokinetic theory, 
thus it is the first candidate to use it for AIF modeling purposes. As shown in [18], it 
can well approximate the indicator kinetics but this study was intended for long time 
measurements (approx. an hour) with low temporal resolution, which is not 
appropriate for DCE-MRI applications (measurements done for several minutes). 
However, the model can still be used for dynamic short-time applications, but 
the time constants of the exponentials differ [19] from those obtained in [18]. This 
was pointed out in [20].  
 The model has a standard form [19]: 
          
        
     (2.29) 
where       are scale constants, the sum       gives the maximum 
of the (first) peak, and       are decay constants of the fast and slow processes, 
respectively [21]. the time-domain description can be transformed to the Laplace 
domain to facilitate the computation of convolution giving: 
       
  
    
 
  
    
  (2.30) 
Example shapes of the time- and frequency-domain representations is shown in 
Figure 2.12. 
Gamma-variate model 
The previous model does not take the initial rise of the bolus into account, 
because it is not designed for high sampling rates. This can be overcome using 
a gamma-variate function for the bolus function [19], which gives: 
            
         
             (2.31) 
This function can again be transformed to the Laplace domain: 
       
  
         
      
 
      
  
 
     
  (2.32) 
 The shape of the functions (without windowed version) is shown in Figure 2.12 
for comparisons with other models. 
Cosine model 
 Since the gamma-variate model suffers from discontinuities of the first 
derivative at    , the authors of [19] have presented a different model with 
the raised cosine based bolus (see Figure 2.12). the physiological background for such 
function does not exist but still the model can approximate the measured AIFs quite 
well. And as stated in [19], this model can be used instead of Parker's AIF (see 
further) without significant loss in the accuracy of the parameter estimates 
of the impulse response function using EGK model (0). the closed-form solution in 
the time domain containing four parameters (           ) can look complicated: 
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  (2.33) 
but it is not computationally demanding (as stated in [19]). However, it is possible 
to render this function through the Laplace domain, where the closed-form solution 
is simpler: 
       
 
 
 
 
 
 
    
   
 
   
                  
            
       
    
           
    
    
  (2.34) 
Parker model 
 This AIF was created for the approximation of a population averaged AIF 
[22] and has became a standard AIF for simulation purposes and studies, when other 
AIF estimate is not available. However, in the original study [22], the population 
averaged AIF was estimated using the indicator Gd-DTPA-BMA (Omniscan®), so 
this AIF model with parameter estimates from [22] should be used only for studies 
with this indicator. 
  
Figure 2.12: Typical shape of bi-exponential, gamma-variate and cosine models in time (left) and 
Fourier amplitude (right) domains. 
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 This AIF has no physiological background and was designed by the authors 
of [22], which proposed to use two Gaussian functions for the first-pass and second-
pass peaks and an exponential modulated by a sigmoid function to model the rest: 
       
  
     
 
 
      
 
   
 
 
     
          
 
 
   
 (2.35) 
Unfortunately, the transformation to the Laplace domain is not straightforward 
and was not found. 
2.1.3 Delay and dispersion 
 The delay and dispersion are processes undergoing during the passage 
of the indicator through a vascular tree. They become problematic, if the AIF 
estimate is based on indicator concentration inside large artery (global AIF), because 
pharmacokinetic model (section 2.1) is based on the AIF corresponding to the small 
local feeding artery (local AIF). In that case, the global AIF should be corrected for 
delay and dispersion. the processes can be modeled as convolution of the global AIF 
with a vascular transport function (VTF) [23]: 
  
                 
    
    (2.36) 
where   
         
        are indicator concentrations in a local and global artery, 
respectively, and         is the VTF, i.e. the vascular transit time distribution. 
the proper distribution         is in general unknown but Calamante [23] has used 
computational fluid dynamics to validate three candidates defined analytically for 
dispersion modeling and has concluded, that the arterial tree can be modeled as one 
well-mixed compartment resulting in: 
        
 
  
 
 
 
   (2.37) 
where    is the mean vascular transit time. 
 Incorporation of the delay into the model can be done using the substitution: 
        , where      is the so called bolus arrival time (BAT). If it is not 
necessary to consider the dispersion effect or if    is small, it is possible to use this 
substitution in any of the modeled function in (2.5), i.e. in the AIF or the impulse 
residue function to model only the delay of the AIF. However, if applied to 
a sampled discontinuous function (as usual for impulse residue function), there are 
substantial problems with the BATs (see also section 0), which are not equal to an 
integer multiple of the sampling interval as analyzed in [24] or in our contribution 
[1] and Paper I. a sampled function with non-integer BAT can in fact have same 
sample values as the same sampled function with the same but rounded BAT. This 
situation is unacceptable for usual minimization algorithms. Therefore we have 
advised to formulate the time-delay rather in the Fourier domain. This can be 
generalized to the Laplace transform resulting in: 
                          
                 (2.38) 
where   is any of the functions involved in the pharmacokinetic model (2.5). 
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2.2 CONTRAST-AGENT CONCENTRATION MODEL 
 The contrast agents for MRI applications are based on paramagnetic 
gadolinium-based substances which cause shortening of the longitudinal and 
transverse relaxation times    and    of the neighboring water molecules [25]. 
the usually used equation for this effect is [25]: 
  
      
       (2.39) 
where     is the relaxation time of the tissue (background) without the presence 
of the contrast agent,   is the molar concentration of the contrast agent and    is 
the relaxivity of the used contrast agent, which can be found in tables [26], [27]. 
This relation is also valid for    (or transverse effective   
 ) if the subscripts (and 
superscripts) are changed. However,    (  
 ) effects are usually assumed to be 
negligible in DCE-MRI (see section 3.3). 
2.3 MODEL OF MRI SIGNAL 
 As stated in the previous section, contrast agent affects the relaxation times 
of water molecules. However, an MRI scanner does not measure these times directly 
but returns only a signal weighted by    and/or   ,   
 . This mathematical 
description of this weighting depends on the used MRI pulse sequence. the list 
of the suitable pulse sequences for DCE-MRI applications is quite limited. the fast 
two- or three-dimensional T1-weighted spoiled gradient echo (SPGR) sequence is 
the most common technique [28]. the basic theoretical expression for the signal 
intensity when using this sequence is [29], [30]: 
       
          
 
  
  
    
 
  
  
       
 
  
  
 (2.40) 
where       are the echo and repetition times, respectively;   is the flip angle 
and   is a constant dependent on proton density and the system gain. 
 The complete model relating the contrast-agent concentration to the MRI 
signal can be obtained by substituting (2.39) into (2.40): 
                     
       
      
         
       
          
              
          
  (2.41) 
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3  ESTIMATION PROCESS 
 The whole previous section 2  was devoted to the modeling of the DCE-MRI 
data. the necessary models were introduced and then plug into each other to form 
a complete model for generation of MRI signal (2.41). However, the task 
of quantitative DCE-MRI is the inverse operation, i.e. an estimation of the perfusion 
parameters. In this section, a chain of estimation steps will be presented to allow 
proper estimation of the perfusion parameters. 
3.1 SIGNAL MEASUREMENT 
 The first step in a DCE-MRI experiment starts with acquisition of data. Using 
an MRI scanner with a suitable pulse sequence (e.g. SPGR) provides us with a time-
series of T1-weighted images. Observing one voxel in time gives samples 
of estimates of the assumed model      , which should be, in a simplified way, 
written as: 
                                                     (3.1) 
where the Dirac function   represents sampling points,   represents 
the measurement window defined as: 
         
         
          
  (3.2) 
where    is the duration of the measurement; and   represents the measurement 
noise. the realizations of the random process,             , can be described by 
the Gaussian distribution with zero mean and the standard deviation  . 
3.2 ESTIMATION OF TISSUE RELAXATION TIME T10 AND SCALING 
FACTOR M0 
 Estimation of the contrast agent concentration is based on the model 
of the pulse sequence, (2.41) for SPGR, but this equation contain additional three 
unknowns:         
  and   , which must be also estimated for each voxel (the    
  
term is neglected because it is negligible due to short TE and is hidden in   ). For 
this purpose, DCE-MRI measurement process contains acquisition of a few images 
before the contrast-agent administration using several different flip angles [31] (see 
[30] for other techniques). the unknowns    and      are then estimated by fitting 
of the non-linear model          
   (2.40) to the measured pre-contrast data. Since 
the non-linear regression is demanding, it can be substituted by a linear one using 
a method presented in [32]. 
3.3 ESTIMATION OF CONTRAST-AGENT CONCENTRATION 
 The following step in DCE-MRI is usually to convert the measured voxel-
specific time signals       , where    is the sampling period and   is the time 
index, to the contrast-agent concentration time curves to simplify further processing. 
However this comfort simplification is controversial (see section 3.5) and if the full 
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equation for SPGR sequence is used (2.41), the income is disputable since 
the inversion         
            must be solved numerically. 
 However, assuming negligible   
  effects (valid for short   ), the inversion 
has closed-form expression [29]: 
          
          
 
 
  
 
 
  
   
                         
                       
     
       
(3.3) 
where      
 
  
    and: 
       
             
      
  (3.4) 
The term        is the complete measured signal recorded during the contrast-
agent distribution,        is the pre-contrast signal, which is usually estimated as an 
average of the samples of        before the arrival of the contrast agent. 
 The non-linear function    
   can even be approximated by a linear function 
    
   for low contrast-agent concentrations yielding [29]: 
           
           
      
     
     (3.5) 
This linear conversion is commonly used despite the fact, that it is not sufficiently 
accurate as shown in [28]. the use of the non-linear closed form solution (3.3) is 
justifiable but the numerical solution of (2.41) should be preferred [29]. the best 
option is, however, to directly estimate pharmacokinetic parameters from the signal, 
thus never explicitly solve for the concentration (see section 3.5). 
3.4 ESTIMATION OF AIF 
 The fundamental problem in perfusion modeling is estimation of a suitable 
AIF. the accuracy of the AIF estimate is crucial, although many authors ignore this 
fact by shortly mentioning their source of AIF or not mentioning it at all. 
the possibilities how to estimate the AIF are presented shortly in this section. 
Signal from voxel within artery 
 This standard technique is used in many practical studies. Signal intensity 
from a voxel within a (feeding) artery is converted to concentration as other voxels 
and used as the AIF. the benefit of this method is that it is possible to get individual 
(patient specific) AIFs. However, the measurement can be complicated, since it 
requires a suitable high-time-resolution acquisition protocol to properly sample 
the AIF in time, i.e. to follow the dynamics of the AIF and to avoid the acquisition-
specific artifacts, such as partial volume [33] and inflow effects [34]. In addition, 
expert knowledge is needed to select a proper voxel if there is any present in 
the image at all. 
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Population average 
 If the dataset does not contain any suitable arterial voxel or the AIF is 
evidently distorted by acquisition artifacts and can not be repaired, use 
of a literature-based population averaged AIF may be a solution. the most popular 
form of a population based AIF was derived by Parker et.al. [22] and was presented 
in section 2.1.2. However, the population-based AIFs must be used carefully, since 
they are derived only for particular injection protocol and a particular contrast agent 
and should not be used in different situations. 
Blind estimation 
 The last group of methods to estimate the AIF, when the previous ones are not 
possible or satisfactory, is blind estimation or identification of the AIF. This method 
is based on processing of only the measured tissue concentration curves. Since 
the model (2.5) contains convolution, it performs an inversion of this operation, i.e. 
deconvolution, without knowledge of the signal     , hence also the term “blind 
deconvolution”. Such a problem is in general ill-posed and needs additional 
information about the signals to be deconvolved. Such additional information is 
usually a certain type of smoothness imposed on the resulting signals or 
the convolution components are explicitly defined by a model, parameters of which 
are to be estimated. Since the method separates two components, both concepts can 
be combined. I.e. one component can be constrained by a model and the other one 
by a smoothing term. This was shown e.g. in [35] where they imposed polynomial 
smoothness on the AIF together with the extended general kinetic model. Another 
option used in [36], [37] and [38] is to constrain both curves by models. In that case 
it is necessary to solve a non-linear regression problem (see section 0). 
 The possibilities of AIF blind estimation were also investigated by our group 
and we have developed several blind estimation algorithms. the main contribution 
of our approach was that, to the best of our knowledge, we have been the first who 
applied more complex (and more realistic) models of the impulse residue function 
(ATH and DCATH) in the context of blind AIF estimation, compared to the so far 
used GK or EGK models.  
 The first method is single-channel deconvolution (Paper II) based on Lucy-
Richardson deconvolution approach and the ATH model for impulse response 
function. the methodology was presented in Paper II and its application to 
a preclinical study of cancer treatment in Paper III and a conference [39]. 
3.5 ESTIMATION OF PHARMACOKINETIC PARAMETERS 
 The core of the dynamic contrast enhanced imaging is to estimate perfusion 
(and microcirculation) parameters of a tissue. the parameters define the shape 
of the impulse residue function, which is convolved with the AIF (2.5). If the AIF 
(or the parameters of it) is estimated in advance (section 3.4), the estimation process 
leads to a non-blind deconvolution problem. If not, it leads to blind deconvolution. 
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I.e. in blind deconvolution it is necessary to restore both the AIF and      from 
the measured signal and in non-blind deconvolution, only      needs to be restored. 
 The type of the restoration process is based on the definition 
of the convolution components. If they are defined analytically, using e.g. 
the models in sections 2.1.1 and 2.1.2, it is usually called the parametric approach 
(or model-based analysis) and its output are directly the parameters of interest. If 
the signals are defined by its samples, it is a non-parametric approach (or model-free 
analysis), which will return function(s) defined by the sample values. To estimate 
the perfusion parameters from a non-parametric impulse residue function, it is 
necessary to use the general properties described by (2.6)–(2.8). the estimated 
sampled impulse residue function can also be fitted by a model, which will form 
a combined method (Paper II). 
 For both approaches, the pharmacokinetic parameters   (or sample values, 
e.g. if              ) are estimated by a general minimization process: 
      
 
           (3.6) 
where   is a criterial (or penalty, risk, ...) function and    are error terms. 
the error term    is the so called data term and it is a difference between 
the measurement        and a model        : 
                                             (3.7) 
where         stands for pure (true) signal and      is the measurement noise, i.e. 
a sequence of realizations of a random process described by its probability 
distribution (see section 3.1). the other error terms stand for additional information 
about the process and need not to be used. Even though the data term looks simple, 
it need not to be so, because as shown in section 2.3,         is not a function 
of the parameters of interest directly but it is a function of contrast-agent 
concentration. To get to the core of the model, i.e. to the pharmacokinetic model 
(2.5), it is necessary to apply a conversion function on one of the summand in (3.7). 
For practical purposes, the measured signal is usually converted to concentration, 
because it is possible to do the conversion in advance resulting in: 
  
                                  (3.8) 
where     is an inversion of the signal generation process (e.g. (3.3) or (3.5)). 
the possible complication of such an approach is that        contains 
a measurement noise and its distribution will be modified by such (nonlinear) 
conversion (see section 3.3). This can break the noise normality assumption (see 
section 3.5.2), thus the optimization process should be performed on the signal level, 
i.e.: 
  
                                (3.9) 
as also suggested by other authors [2], [25] and is supported by the analysis in 
[40]. 
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3.5.1 Convolution integral 
 The core in the estimation of the perfusion parameters is the computation 
of the convolution integral, which operates on continuous functions. Because 
of the discrete nature of the MRI measurement (3.1) and the discrete computation 
environment, the discrete variants of the involved functions 
(                       ) are to be used and the measured signal is approximated 
using discrete convolution: 
                        
 
  
                    
   
   
 (3.10) 
where   is the number of samples of the AIF and    is the discretization 
function. Because the computation of this sum is inefficient for signals longer than 
a few samples, it is usually replaced by the discrete Fourier transform and its 
inverse, both performed by Fast Fourier transform algorithm (FFT): 
                        
 
  
                                    (3.11) 
where       means the inverse FFT. However, this approach is performing 
circular convolution, so the input signals must be zero-padded before calling 
the FFT to have     samples to avoid time-domain aliasing. the convolution 
output must then be cropped back to  valid samples. 
 As pointed out in [24], the approximation (3.10) is even insufficiently precise 
(see section 0), since the numerical integration is based on a basic rectangle rule, 
which is inappropriate for functions with steps (e.g. the ATH model of the impulse 
residue function, but generally every impulse residue function model has a step at 
   ). a relatively simple solution is to use a different numerical technique based 
on the trapezoidal rule as proposed in [24]. However, it is still an approximation. 
 A correct solution is to derive a closed-form formula for        , which is 
possible only for some parametric models of both convolution components. 
the solution for the ATH model (2.24) and the AIF of the form (2.31) can be found 
in [24]. 
 It is often not possible to derive a closed-form solution, e.g. because the AIF 
exists as a sampled signal or because the convolution integral simply does not have 
a closed-form solution. However, there is still an elegant solution coming from 
the deeper analysis of the convolution integral and the properties of the exponential 
transforms. the principle was published in [11] for the TH model but in 
the following text it will be generalized also for other models including the AIF 
models. the continuous-time-domain convolution can be rewritten to the Fourier 
domain: 
                   
                      
                   (3.12) 
Substituting the Fourier transform by FFT for discrete signals simply yields 
(3.11), but using the relation between the Fourier transform and the Laplace 
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transform (i.e. the Fourier transform for causal signals is the Laplace transform if 
    ), (3.12) transforms to: 
                              (3.13) 
This equation can be rewritten for discrete signals using           and 
the sampled version of the signals spectra: 
                          
                    
                              
(3.14) 
where    
  
    
 and   is the number of samples after zero-padding needed to 
avoid time-domain aliasing,             , but its concrete form of   depends 
on the implementation of FFT algorithm. This approach allows an implementation 
of the impulse residue models described only in the Laplace domain as proposed in 
[11] for the TH model. But it can be beneficial for other models as well (e.g. the DP 
model which has a complicated time-domain solution containing Bessel function). 
the benefit of this approach also lies in the computation acceleration since the FFT is 
the most demanding operation and if the functions are rendered in the Fourier 
domain, it saves at least one computation of the FFT per iteration. the speed-up 
factor can be higher, because the computations of the gradients needed for 
the optimization algorithm are not taken into account. 
3.5.2 Likelihood approach 
 Despite the general title of this section, it is devoted only to nonlinear 
regression using the non-linear least mean squares (LMS) method, which is the most 
common method in DCE-MRI. However, the corrected maximum likelihood 
estimator derived for non-Gaussian noise (3.8) has also been presented for DCE-
MRI and compared to the LMS method [40]. 
 To analyze all assumptions needed for the LMS method to find an unbiased 
estimate of the parameters is beyond the scope of this thesis and can be found 
elsewhere, e.g. in [41]. the important assumption is that the noise in 
the measurement must be normal with a constant variance. This is not valid in all 
DCE-MRI situations (e.g. because of nonlinear processing of the measured signal) 
and it is analyzed in [40]. 
 The criterial function   in (3.6) for LMS has the form: 
            
 
   
              
 
   
   
 
   
 (3.15) 
where summation over   stands for observations, i.e. concentration curves in 
different tissues (voxels). If the curve-fitting is done independently as usual, then 
    and the sum disappears. the data term     is defined either by (3.8) or (3.9) 
with the difference, that it assumes an analytical model            and    is 
a vector of parameters in the particular tissue (voxel) to be found. 
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Traditional concept 
 The standard concept in DCE-MRI experiments supposes to have measured 
data already converted to represent the contrast-agent concentration (section 3.3) or 
that the measured signal intensity is directly proportional to the concentration. 
Furthermore, the AIF is estimated separately in advance (see section 3.4) and 
the measured signals are treated separately, voxel-by-voxel. Then,.(3.15) has 
the form: 
      
   
                                
 
 
   
 (3.16) 
with the convolution integral usually solved using the FFT (3.11). This is not an 
optimal approach. As shown in [11], [24] and our paper [1], rendering discontinuous 
          in the time domain causes discontinuities in the criterial function, which 
leads to a failure in the minimization procedure, because the discontinuities cause 
local minima. 
 However, even if these induced minima would not be present (when a better 
computation technique for the calculation of the convolution is used, section 3.5.1), 
other local minima could be present, because it is a general problem in non-linear 
regression [41]. 
 Assuming that the proper minimum has been selected, it is important (and in 
the literature mostly ignored) to estimate the confidence intervals of the estimated 
perfusion parameters. It can be based on characterization of the shape of the criterial 
function around the solution. This can be done by estimation of the covariance 
matrix from the gradients of the fitted model [41]. Although it is only an 
approximation of the true probability distribution of the estimates by 
the multivariate normal distribution, it can be very useful. This issue was 
investigated in Paper I. 
Blind estimation 
 The blind estimation methods are based on simultaneous estimation 
of the parameters of both convolution components, i.e. the AIF and the impulse 
residue function. Adopting (3.15) for general blind LMS estimation results in: 
      
      
     
                                      
 
 
   
 
   
 (3.17) 
where    is the vector of parameters of the AIF model,    is a vector of parameters 
of the impulse residue function of the o
th
 tissue (voxel),         is the measured 
signal in the o
th
 tissue (voxel) and      stands for the domains of definitions (i.e. 
constrains) for the parameters of the impulse response function and the AIF, 
respectively. the main idea behind this concept is that multiple tissues share 
the same AIF. Several variants of blind multichannel deconvolution have been 
presented by the group of di Bella [36], [37], [38], [42], [43] with the EGK model 
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and a special AIF with 11 parameters based on gamma-variate functions. Promising 
results were also presented by our group with the DCATH model and Parker's AIF 
[44], [45]. 
 A special problem in blind estimation is the scale of the AIF or equivalently, 
the scale of the impulse residue function, since the scaling factors of these functions 
are inversely proportional. a possible solution of this problem is to scale the AIF 
estimate using a measurement of the AIF tail as suggested in [42] or using 
a literature-based perfusion-parameter (e.g. plasma volume + EES volume) in 
a reference tissue as used in Paper III. 
3.5.3 Bayesian approach 
 Another approach to estimation of the impulse residue function or its 
parameters is based on Bayesian inference. the general concept of the estimation is 
similar (beginning of section 3.5), but the theoretical background is different and it 
is beyond the scope of this thesis to describe differences and possible similarities, 
which may arise. 
Non-parametric approach 
 At the early phase of DCE-MRI (or rather DSC-MRI), standard estimators 
known from general signal processing theory were used, such as singular volume 
decomposition (SVD), [46], [47], Wiener filter [48] or Lucy-Richardson Paper II. 
Because the complete signal needs to be estimated from noisy data, these methods 
were not sufficiently robust. Hence, they were extended by an a priori knowledge 
about the signals, such as smoothness and monotonicity (in case of the impulse 
response function) to reduce their sensitivity to noise. Many authors have presented 
their regularization variants of the Tichonov regularization [23], [49], penalized 
monotonicity [46], constrained monotonicity [50], monotonicity constrained splines 
[51]or penalty B-splines [52]. the regularization possibilities are well analyzed by 
Keeling et al. in [53] or [54], where they have presented estimation of the impulse 
response function using an exponential basis. 
 Unlike the [54], these methods are model-free in the sense of physiological 
models described in (section 2.1.1). the possibility of imposing model-based 
regularization on deconvolution was shown by our group in Paper II, where we 
have presented an alternating minimization scheme with Lucy-Richardson 
deconvolution using total variation regularization and adiabatic tissue homogeneity 
model for blind estimation. 
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Paper I 
The precision of DCE-MRI using the tissue homogeneity model 
with continuous formulation of the perfusion parameters 
Michal Bartoš, Radovan Jiřík, Jiří Kratochvíla, Michal Standara, Zenon Starčuk, 
Torfinn Taxt 
 
Abstract 
The present trend in dynamic contrast-enhanced MRI is to increase the number 
of estimated perfusion parameters using complex pharmacokinetic models. 
However, less attention is given to the precision analysis of the parameter estimates. 
In this paper, the distributed capillary adiabatic tissue homogeneity pharmacokinetic 
model is extended by the bolus arrival time formulated as a free continuous 
parameter. With the continuous formulation of all perfusion parameters, it is 
possible to use standard gradient-based optimization algorithms in 
the approximation of the tissue concentration time sequences. This new six-
parameter model is investigated by comparing Monte-Carlo simulations with 
theoretically derived covariance matrices. the covariance-matrix approach is 
extended from the usual analysis of the primary perfusion parameters 
of the pharmacokinetic model to the analysis of the perfusion parameters derived 
from the primary ones. the results indicate that the precision of the estimated 
perfusion parameters can be described by the covariance matrix for signal-to-noise 
ratio higher than ~20dB. the application of the new analysis model on a real DCE-
MRI data set is also presented. 
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Bartoš M, Jiřík R, Kratochvíla J, Standara M, Starčuk Z, Taxt T. the precision 
of DCE-MRI using the tissue homogeneity model with continuous formulation 
of the perfusion parameters. Magn Reson Imaging 2014;32:505–13. 
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Paper II 
Single-channel blind estimation of arterial input function and 
tissue impulse response in DCE-MRI 
Torfinn Taxt, Radovan Jiřík, Cecilie Brekke Rygh, Renate Grüner, Michal Bartoš, 
Erling Andersen,Fitz-Roy Curry and Rolf K. Reed 
 
Abstract 
Multipass dynamic MRI and pharmacokinetic modeling are used to estimate 
perfusion parameters of leaky capillaries. Curve fitting and nonblind deconvolution 
are the established methods to derive the perfusion estimates from the observed 
arterial input function (AIF) and tissue tracer concentration function. These nonblind 
methods are sensitive to errors in the AIF, measured in some nearby artery or 
estimated by multichannel blind deconvolution. Here, a single-channel blind 
deconvolution algorithm is presented, which only uses a single tissue tracer 
concentration function to estimate the corresponding AIF and tissue impulse 
response function. That way, many errors affecting these functions are reduced. 
the validity of the algorithm is supported by simulations and tests on real data from 
mouse. the corresponding nonblind and multichannel methods are also presented. 
 
Reference: 
Taxt T, Jiřík R, Rygh CB, Grüner R, Bartoš M, Andersen E, et al. Single-channel 
blind estimation of arterial input function and tissue impulse response in DCE-MRI. 
IEEE Trans Biomed Eng 2012;59:1012–21. 
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Paper III 
Anti-VEGF treatment reduces blood supply and increases 
tumor cell invasion in glioblastoma 
Olivier Keunen, Mikael Johansson, Anaïs Oudin, Morgane Sanzey, Siti A. Abdul 
Rahim, Fred Fack, Frits Thorsen, Torfinn Taxt, Michal Bartos, Radovan Jirik, 
Hrvoje Miletic, Jian Wang, Daniel Stieber, Linda Stuhr, Ingrid Moen, Cecilie 
Brekke Rygh, Rolf Bjerkvig, and Simone P. Niclou 
 
Abstract 
Bevacizumab, an antibody against vascular endothelial growth factor (VEGF), is 
a promising, yet controversial, drug in human glioblastoma treatment (GBM). Its 
effects on tumor burden, recurrence, and vascular physiology are unclear. We 
therefore determined the tumor response to bevacizumab at the phenotypic, 
physiological, and molecular level in a clinically relevant intracranial GBM 
xenograft model derived from patient tumor spheroids. Using anatomical and 
physiological magnetic resonance imaging (MRI), we show that bevacizumab 
causes a strong decrease in contrast enhancement while having only a marginal 
effect on tumor growth. Interestingly, dynamic contrast-enhanced MRI revealed 
a significant reduction of the vascular supply, as evidenced by a decrease in 
intratumoral blood flow and volume and, at the morphological level, by a strong 
reduction of large- and medium-sized blood vessels. Electron microscopy revealed 
fewer mitochondria in the treated tumor cells. Importantly, this was accompanied by 
a 68% increase in infiltrating tumor cells in the brain parenchyma. At the molecular 
level we observed an increase in lactate and alanine metabolites, together with an 
induction of hypoxia-inducible factor 1α and an activation of the phosphatidyl-
inositol-3-kinase pathway. These data strongly suggest that vascular remodeling 
induced by anti-VEGF treatment leads to a more hypoxic tumor microenvironment. 
This favors a metabolic change in the tumor cells toward glycolysis, which leads to 
enhanced tumor cell invasion into the normal brain. the present work underlines 
the need to combine anti-angiogenic treatment in GBMs with drugs targeting 
specific signaling or metabolic pathways linked to the glycolytic phenotype. 
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VEGF treatment reduces blood supply and increases tumor cell invasion in 
glioblastoma. Proc Natl Acad Sci U S a 2011;108:3749–54. 
Available online: http://www.pnas.org/content/108/9/3749 
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4  CONCLUSION 
 The first part of this dissertation describes the necessary theoretical 
background for quantitative DCE-MRI. This part should contribute to understanding 
of our contribution made and described in the presented papers. DCE-MRI includes 
a chain of estimations from measuring of the MRI signal to the estimation 
of perfusion and microcirculation tissue parameters, which is the goal of quantitative 
DCE-MRI. the described chain was also transformed to a computer application, 
implemented by our group in the Matlab (Mathworks, Inc., Natic, US-MA) 
environment. This has contributed to a comfortable processing of datasets used not 
only in the presented papers in the second part of the dissertation. 
 Paper I contains two major contributions. First, a novel method for 
elimination of the step-wise discontinuous character of the criterial function to be 
minimized was proposed. This discontinuity is caused by the initial step 
of the impulse residue functions at the bolus arrival time (any model) and at the end 
of the vascular distribution phase (ATH and DP models). Analysis of this problem 
was also presented in our conference contribution [1] and in papers of other authors 
[11], [24]. We have solved this problem by performing the time-shift of the model in 
the Fourier domain and by using the DCATH model of the impulse residue function 
as presented in Paper I. 
 The second contribution in Paper I is our method for calculation of precision 
of the perfusion-parameter estimates. This is of great importance for the DCE-MRI 
studies, because reliable conclusions from the perfusion-parameter estimates can be 
drawn only when their confidence intervals are known. 
 Paper II is a result of collaboration with professor Torfinn Taxt. 
the underlying work of this paper started during my one-semester stay at his 
institution (University of Bergen). the main contribution of this paper is to allow 
processing of DCE-MRI datasets without having measured the arterial input 
function, and thus avoiding the related measurement artifacts. This could be done 
using blind deconvolution techniques. Namely using the Lucy-Richardson 
alternating minimization (also analyzed in our conference contribution [55]) with 
imposed analytical model of the impulse residue function and total variation 
regularization as presented in Paper II. 
 Another possibility to the blind estimation of the AIF is nonlinear regression. 
This is presented in our contributions [44], [45], [56] and [57], which are based on 
the extended DCATH model from Paper I and complex model-based AIFs. 
 All the concepts presented in Paper I and Paper II were used in a preclinical 
study of anti-angiogenic (reduction of tumor-vasculature growth) therapy response 
of glioblastoma presented in Paper III. We have shown on animal models that 
quantitative DCE-MRI is a powerful tool for assessment of perfusion and 
microcirculation of tumor environment. This was cross-validated with other methods 
such as histology, since this is still the only way to validate the new information 
gained from improved DCE-MRI. 
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